Tissue plasminogen activators in breast cancer

• Published in: Thrombosis research Vol. 45; no. 5; p. 601
• Main Authors: Layer, G T, Burnand, K G, Gaffney, P J, Cederholm-Williams, S A, Mahmoud, M, Houlbrook, S, Pattison, M
• Format: Journal Article
• Language: English
• Published: United States 01-03-1987
• Subjects: Breast Neoplasms - analysis; Breast Neoplasms - enzymology; Enzyme-Linked Immunosorbent Assay - methods; Female; Fibrinolysis; Humans; Tissue Extracts - analysis; Tissue Plasminogen Activator - analysis; Tissue Plasminogen Activator - antagonists & inhibitors; Tissue Plasminogen Activator - metabolism; Urokinase-Type Plasminogen Activator - analysis; Urokinase-Type Plasminogen Activator - metabolism
• ISSN: 0049-3848
• DOI: 10.1016/0049-3848(87)90323-9

Increased levels of tissue fibrinolytic activity have been detected in some malignant tumours and they have been implicated in metastatic spread. We have investigated tissue plasminogen activator (tPA) and urokinase (UK) in 26 breast carcinomas and 13 benign breast biopsies. Tissue extracts were analysed for overall fibrinolytic activity on fibrin plates and by fibrin-overlay zymography after electrophoresis on SDS-PAG. Supernatants of the extracts were analysed by an antigenic immunoassay (ELISA) and a functional bioimmunoassay (BIA) using polyclonal antibodies. Total ELISA and BIA results correlated (P less than 0.001) and all the tissues contained similar tPA levels. Malignant extracts contained significantly increased UK compared with benign extracts (1.60 +/- 0.37 iu, 0.36 +/- 0.16 iu; P less than 0.002). Zymography showed no high molecular weight inhibitor complexes and UK was almost exclusively confined to the malignant tissues (P much less than 0.02). The results suggest that malignant transformation of breast tissue is associated with the significantly increased production of UK. This may be responsible for the characteristics of malignancy or it may be a growth factor.